W. Boersma (Oudorp, The Netherlands), S. L. Johnston (Norfolk Place, UK)
Influenza A virus in exacerbation of chronic obstructive pulmonary disease (COPD)
G. Rohde, A. Wiethege, I. Borg, U. Arinir, A. Schuermann, S. Loeseke, M. Kauth, A. Bufe, G. Schultze-Werninghaus (Bochum, Germany)
|  |
Risk factors for bacterial infection in exacerbated COPD requiring admission
E. Monso, J. Garcia-Aymerich, N. Soler, E. Farrero, M. A. Felez, A. Torres, J. M. Anto, The EFRAM Investigators (Badalona, Barcelona, Hospitalet de Llobregat, Spain)
| |
The effect of 3 months oral clarithromycin on sputum bacterial colonization in stable moderate- to- severe chronic obstructive pulmonary disease (COPD)
D. Banerjee, E. Clarke, S. L. Hill, D. Honeybourne, O. Khair (Birmingham, United Kingdom)
| |
Decline in FEV1 is faster with frequent exacerbations of COPD
G. C. Donaldson, T. A. Seemungal, A. Bhowmik, J. A. Wedzicha (London, United Kingdom)
| |
Inflammation and infection in chronic obstructive lung disease assessed according to sputum colour
S. L. Hill, A. Pye, S. Gompertz, R. A. Stockley (Birmingham, United Kingdom)
| |
Relationship between systemic IFNγ and IL5 levels and exacerbation frequency in COPD
I. S. Patel, T. A. R. Seemungal, S. J. Lloyd-Owen, R. J. Sapsford, J. A. Wedzicha (London, United Kingdom)
| |
The balance of pro- and anti - inflammatory cytokines in Chlamydia pneumoniae infected cells as a marker of inflammatory activity in the pulmonary compartment
J. Rupp, H. Kothe, A. Müller, H. A. Katus, K. Dalhoff (Lübeck, Germany)
| |
Detection of chlamydia infection in smooth muscle cells of bronchiolar walls and pulmonary vessels in advanced emphysema
D. Theegarten, S. Klafke, O. Anhenn (Bochum, Germany)
| |